ニュース
Direct access to Wegovy® (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership ...
Topline data were announced from a phase 3 trial evaluating zanzalintinib in combination with atezolizumab in patients with previously treated non-microsatellite instability (MSI)-high metastatic ...
Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics ...
Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide ...
Topline results were announced from a phase 3 study evaluating sotatercept-csrk in recently diagnosed adults with pulmonary arterial hypertension (PAH).
A single dose of a synthetic, proprietary formulation of psilocybin (COMP360) was found to improve symptoms in patients with treatment-resistant ...
HealthDay News — Cannabis use is associated with major adverse cardiovascular events (MACE), according to a systematic review based on real-world data published online June 17 in Heart.
Through August 16, 2024, the Agency has identified 13 cases worldwide of hyperthermia associated with scopolamine patches.
Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.
The Food and Drug Administration (FDA) has approved Monjuvi ® (tafasitamab-cxix), in combination with lenalidomide and rituximab, for the treatment of adult patients with relapsed or refractory (R/R) ...
Her team documented a cluster of emergency calls in New Jersey last year linked to a flavored elixir called Neptune’s Fix, which contained tianeptine. After drinking it, people experienced rapid ...
Unvaccinated patients had higher rate of continuous renal replacement therapy during hospitalization and higher rate of being discharged on RRT ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する